TCM Biotech International Corp.

TCM Biotech International Corp. was established in 1998 as a company specializing in innovative Chinese herbal drug development. In the years since, we have been steadily building up our research, development and manufacturing capabilities, with the establishment of a modern drug R&D center, as well as a fermentation and extraction pilot plant. From the lab to store shelf, TCM Biotech takes each product from the earliest stages of discovery and development through to testing, manufacturing, scale up, and marketing. The company already has a number of successful products on the market derived from Chinese herbal drugs, and is constantly working to develop innovative new products for the benefit of your health.

In recent years, TCM Biotech has been focusing on the development of new drugs from the Chinese medicinal ingredients Cordyceps sinensis, Antrodia comphoratomycelia, and Rhodiola rosea L., including full pharmacology, toxicology and clinical efficacy evaluation. A Phase II clinical protocol has been approved by the US FDA as well as Taiwan's Department of Health (DOH) to test the efficacy of adding TCM Biotech's new drug candidate TCM-700C to the conventional chemical drug treatment for chronic hepatitis C infection, with patient enrollment for this trial already begun.